{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:04:00Z","timestamp":1791677040502,"version":"4.3.4"},"reference-count":27,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.4103\/ijnm.ijnm_77_23","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T03:00:06Z","timestamp":1697166006000},"page":"201-207","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["India's Growing Nuclear Medicine Infrastructure and Emergence of Radiotheranostics in Cancer Care: Associated Challenges and the Opportunities to Collaborate"],"prefix":"10.25259","volume":"38","author":[{"given":"Baljinder","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine and PET, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanshyam","family":"Sahani","sequence":"additional","affiliation":[{"name":"Division of Radiological Safety, Medical Applications Section, Atomic Energy Regulatory Board, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Prasad","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, WUSTL, St. Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Watts","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, AIIMS, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2023,10,10]]},"reference":[{"key":"R1-20240902","doi-asserted-by":"crossref","first-page":"20201041","DOI":"10.1259\/bjr.20201041","article-title":"Long-term outcome of indigenous (177) Lu-DOTATATE PRRT in patients with metastatic advanced neuroendocrine tumours: A single institutional observation in a large tertiary care setting","volume":"94","author":"Sitani","year":"2021","journal-title":"Br J Radiol"},{"key":"R2-20240902","doi-asserted-by":"crossref","first-page":"e0251375","DOI":"10.1371\/journal.pone.0251375","article-title":"Long-term outcome of 177Lu-PSMA-617 radioligand therapy in heavily pre-treated metastatic castration-resistant prostate cancer patients","volume":"16","author":"Yadav","year":"2021","journal-title":"PLoS One"},{"key":"R3-20240902","first-page":"2208","article-title":"A phase II clinical study on 225Ac-DOTATATE therapy in advanced stage gastroenteropancreatic neuroendocrine tumor patients","volume":"63","author":"Bal","year":"2022","journal-title":"J Nucl Med"},{"key":"R4-20240902","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.7150\/thno.48107","article-title":"Efficacy and safety of (225) Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant prostate cancer patients","volume":"10","author":"Yadav","year":"2020","journal-title":"Theranostics"},{"key":"R5-20240902","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s12149-021-01617-4","article-title":"Therapeutic efficacy of (225) Ac-PSMA-617 targeted alpha therapy in patients of metastatic castrate resistant prostate cancer after taxane-based chemotherapy","volume":"35","author":"Sen","year":"2021","journal-title":"Ann Nucl Med"},{"key":"R6-20240902","doi-asserted-by":"crossref","first-page":"20211272","DOI":"10.1259\/bjr.20211272","article-title":"Imaging CXCR4 receptors expression for staging multiple myeloma by using (68) Ga-Pentixafor PET\/CT: Comparison with (18) F-FDG PET\/CT","volume":"95","author":"Shekhawat","year":"2022","journal-title":"Br J Radiol"},{"key":"R7-20240902","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00259-017-3622-7","article-title":"68Ga-Pentixafor PET\/CT demonstrating higher CXCR4 density in small cell lung carcinoma than in non-small cell variant","volume":"44","author":"Watts","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R8-20240902","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2967\/jnmt.122.264141","article-title":"(68) Ga-Pentixafor PET\/CT demonstrating in vivo CXCR4 receptor overexpression in rare lung malignancies: Correlation with histologic and histochemical findings","volume":"50","author":"Watts","year":"2022","journal-title":"J Nucl Med Technol"},{"key":"R9-20240902","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s00259-022-06059-2","article-title":"[(68) Ga] ga-pentixafor PET\/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: Correlation with quantitative receptors\u2019 density by immunochemistry techniques","volume":"50","author":"Watts","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R11-20240902","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3390\/ph14121212","article-title":"First-in-human results on the biodistribution, pharmacokinetics, and dosimetry of [(177) Lu] Lu-DOTA.SA.FAPi and [(177) Lu] Lu-DOTAGA.(SA.FAPi)(2)","volume":"14","author":"Ballal","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"R12-20240902","first-page":"65","article-title":"Novel fibroblast activation protein inhibitor-based targeted theranostics for radioiodine-refractory differentiated thyroid cancer patients: A pilot study","volume":"32","author":"Ballal","year":"2022","journal-title":"Thyroid"},{"key":"R13-20240902","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2967\/jnumed.120.256271","article-title":"FAPI PET\/CT: Will it end the hegemony of (18) F-FDG in Oncology?","volume":"62","author":"Hicks","year":"2021","journal-title":"J Nucl Med"},{"key":"R14-20240902","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1148\/radiol.204066","article-title":"Safety and diagnostic yield of (68) ga prostate-specific membrane antigen PET\/CT-guided robotic-assisted transgluteal prostatic biopsy","volume":"303","author":"Kumar","year":"2022","journal-title":"Radiology"},{"key":"R15-20240902","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: The EANM standardized reporting guidelines v1.0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R16-20240902","doi-asserted-by":"crossref","first-page":"12509","DOI":"10.1021\/acsomega.1c04256","article-title":"[(99m) Tc] Tc-DTPA-Bis (cholineethylamine) as an oncologic tracer for the detection of choline transporter (ChT) and choline kinase (ChK) expression in cancer","volume":"7","author":"Jaswal","year":"2022","journal-title":"ACS Omega"},{"key":"R17-20240902","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/RLU.0000000000001943","article-title":"Differentiation of recurrent\/residual glioma from radiation necrosis using semi quantitative 99mTc MDM (bis-methionine-DTPA) brain SPECT\/CT and dynamic susceptibility contrast-enhanced mr perfusion: A comparative study","volume":"43","author":"Rani","year":"2018","journal-title":"Clin Nucl Med"},{"key":"R18-20240902","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10967-021-07859-w","article-title":"Radiosynthesis of [18F] flumazenil for imaging benzodiazepine receptors and its evaluation in human volunteers using simultaneous PET-MRI","volume":"329","author":"Kumar","year":"2021","journal-title":"J Radioanal Nucl Chem"},{"key":"R19-20240902","doi-asserted-by":"crossref","first-page":"18584","DOI":"10.1038\/s41598-022-22930-6","article-title":"Synthesis, characterization, and radiosynthesis of fluorine-18-AVT-011 as a Pgp chemoresistance imaging marker","volume":"12","author":"Kumar","year":"2022","journal-title":"Sci Rep"},{"key":"R20-20240902","doi-asserted-by":"crossref","first-page":"129240","DOI":"10.1016\/j.bmcl.2023.129240","article-title":"Design, characterization and evaluation of a new (99m) Tc-labeled folate derivative with affinity towards folate receptor","volume":"86","author":"Das","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"R21-20240902","first-page":"651","article-title":"Synthesis and biological evaluation of 90Y-labeled porphyrin-DOTA conjugate: A potential molecule for targeted tumor therapy","volume":"28","author":"Mittal","year":"2013","journal-title":"Cancer Biother Radiopharm"},{"key":"R22-20240902","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/RLU.0000000000001409","article-title":"Theranostic treatment of metastatic bone pain with 177Lu-DOTMP","volume":"41","author":"Das","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R23-20240902","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.nucmedbio.2016.02.002","article-title":"Clinical translation of (177) Lu-labeled PSMA-617: Initial experience in prostate cancer patients","volume":"43","author":"Das","year":"2016","journal-title":"Nucl Med Biol"},{"key":"R24-20240902","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.apradiso.2016.12.058","article-title":"Radiochemical studies, pre-clinical investigation and preliminary clinical evaluation of (170) Tm-EDTMP prepared using in-house freeze-dried EDTMP kit","volume":"122","author":"Das","year":"2017","journal-title":"Appl Radiat Isot"},{"key":"R25-20240902","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1039\/D0MD00319K","article-title":"Formulation and clinical translation of [(177) Lu] Lu-trastuzumab for radioimmunotheranostics of metastatic breast cancer","volume":"12","author":"Guleria","year":"2021","journal-title":"RSC Med Chem"},{"key":"R26-20240902","doi-asserted-by":"crossref","first-page":"113184","DOI":"10.1016\/j.ejmech.2021.113184","article-title":"Effect of structural variation on tumor targeting efficacy of cationically charged porphyrin derivatives: Comparative in-vitro and in-vivo evaluation for possible potential in PET and PDT","volume":"213","author":"Guleria","year":"2021","journal-title":"Eur J Med Chem"},{"key":"R27-20240902","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.4103\/0972-3919.362983","article-title":"Radiotheranostics practice in India- advancing to precision oncology","volume":"37","author":"Kumar","year":"2022","journal-title":"Indian J Nucl Med"},{"key":"R28-20240902","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2967\/jnumed.123.265603","article-title":"Theranostic radiopharmaceuticals: A universal challenging educational paradigm in nuclear medicine","volume":"64","author":"Urbain","year":"2023","journal-title":"J Nucl Med"}],"container-title":["Indian Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijnm.ijnm_77_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:37:53Z","timestamp":1779694673000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijnm.co.in\/indias-growing-nuclear-medicine-infrastructure-and-emergence-of-radiotheranostics-in-cancer-care-associated-challenges-and-the-opportunities-to-collaborate\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijnm.ijnm_77_23","relation":{},"ISSN":["0972-3919","0974-0244"],"issn-type":[{"value":"0972-3919","type":"print"},{"value":"0974-0244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"2023-07-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}